z-logo
Premium
Nutrition Modulation of Cachexia/Proteolysis
Author(s) -
Siddiqui Rafat,
Pandya Darshak,
Harvey Kevin,
Zaloga Gary P.
Publication year - 2006
Publication title -
nutrition in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 71
eISSN - 1941-2452
pISSN - 0884-5336
DOI - 10.1177/0115426506021002155
Subject(s) - cachexia , medicine , wasting , anorexia , adipose tissue , endocrinology , catabolism , cancer , metabolism
Cachexia represents progressive wasting of muscle and adipose tissue and is associated with increased morbidity and mortality. Although anorexia usually accompanies cachexia, cachexia rarely responds to increased food intake alone. Our knowledge of the underlying mechanisms responsible for cachexia remains incomplete. However, most states of cachexia are associated with underlying inflammatory processes and/or cancer. These processes activate protein degradation and lipolytic pathways, resulting in tissue loss. In this article, we briefly review the pathophysiology of cachexia and discuss the role of specific nutrient supplements for the treatment of cachexia. The branched chain amino acid leucine, the leucine metaboliteβ ‐hydroxy‐β‐methylbutyrate, arginine, glutamine, ω‐3 long chain fatty acids, conjugated linoleic acid, and polyphenols have demonstrated some efficacy in animal and/or human studies. Optimal treatment for cachexia is likely aimed at maximizing muscle and adipose synthesis while minimizing degradation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here